Femasys (FEMY) Change in Accured Expenses (2020 - 2026)
Femasys (FEMY) posted Change in Accured Expenses of -$193226.0 for Q1 2026, down 37546.9% on a QoQ basis from $516.0 in Q4 2025, and down 1104.35% year-over-year from $19239.0 in Q1 2025.
Femasys (FEMY) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Femasys' Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$193226.0 for Q1 2026.
- Quarterly Change in Accured Expenses fell 1104.35% year-over-year to -$193226.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$235643.0 (down 1095.7% YoY) and the FY2025 annual result came in at -$23178.0, up 36.62% from the prior year.
- Change in Accured Expenses was -$193226.0 for Q1 2026 at Femasys, down from $516.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $874854.0 in Q4 2023 and bottomed at -$516949.0 in Q2 2024.
- A 5-year average of $39511.7 and a median of $516.0 in 2025 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses plunged 63685.36% — and 2025, when it surged 974.58%.
- Femasys' Change in Accured Expenses stood at -$108739.0 in 2022, then jumped by 904.54% to $874854.0 in 2023, then sank by 100.01% to -$59.0 in 2024, then jumped by 974.58% to $516.0 in 2025, then tumbled by 37546.9% to -$193226.0 in 2026.
- Business Quant data shows FEMY's Change in Accured Expenses at -$193226.0 in Q1 2026, $516.0 in Q4 2025, and $74603.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 128.44 Bn | 123.22 Bn | 1.96 Bn | -260.40 Mn |
| 2 | Becton Dickinson | 46.42 Bn | 45.60 Bn | 2.15 Bn | - |
| 3 | Alcon | 33.66 Bn | 32.00 Bn | 1.53 Bn | - |
| 4 | Medline | 33.13 Bn | 30.89 Bn | 1.84 Bn | -32.00 Mn |
| 5 | Resmed | 30.41 Bn | 28.75 Bn | 890.98 Mn | 103.88 Mn |
| 6 | West Pharmaceutical Services | 24.00 Bn | 23.56 Bn | 329.20 Mn | - |
| 7 | Solventum | 14.98 Bn | 14.42 Bn | 1.10 Bn | -151.00 Mn |
| 8 | Cooper Companies | 14.01 Bn | 13.87 Bn | 735.40 Mn | - |
| 9 | Baxter International | 12.51 Bn | 10.49 Bn | 891.00 Mn | 203.00 Mn |
| 10 | Femasys | 13.77 Mn | 8.38 Mn | - | -193,226.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -193,226.00 |
| Mar 31, 2026 | -193,226.00 |
| Dec 31, 2025 | 516.00 |
| Dec 31, 2025 | 516.00 |
| Sep 30, 2025 | 74,603.00 |
| Sep 30, 2025 | 74,603.00 |
| Jun 30, 2025 | -117,536.00 |
| Jun 30, 2025 | -117,536.00 |
| Mar 31, 2025 | 19,239.00 |
| Mar 31, 2025 | 19,239.00 |
| Dec 31, 2024 | -59.00 |
| Dec 31, 2024 | -59.00 |
| Sep 30, 2024 | 521,435.00 |
| Sep 30, 2024 | 521,435.00 |
| Jun 30, 2024 | -516,949.00 |
| Jun 30, 2024 | -516,949.00 |
| Mar 31, 2024 | -40,995.00 |
| Mar 31, 2024 | -40,995.00 |
| Dec 31, 2023 | 874,854.00 |
| Dec 31, 2023 | 874,854.00 |